Francois Montastruc

23PUBLICATIONS
33CO-AUTHORS
Disease surveillanceMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Toxicology (incl. clinical toxicology)Dental therapeutics, pharmacology and toxicology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jun 29, 2026
Do consumers and healthcare professionals report the same adverse event differently? A paired analysis of duplicate vaccine safety reports in Norway.

|Apr 15, 2025
Investigating Risk of Cancer with Sodium-Glucose Cotransporter 2 Inhibitors: A Disproportionality Analysis in the WHO Global Pharmacovigilance Database Vigibase®.

Paul Gautier, Meyer Elbaz, Frédéric Bouisset

|Mar 24, 2025
The use of antipsychotics in the treatment of catatonia: a systematic review.

Maximilien Redon, Jordan Virolle, François Montastruc

|Oct 02, 2023
Quality of reporting of adverse events in clinical trials of covid-19 drugs: systematic review.

Karima Madi, Clara Flumian, Pascale Olivier

|Aug 16, 2023
Sublingual/Buccal buprenorphine and dental problems: a pharmacovigilance study.

Romain Barus, François Montastruc, Claire de Canecaude

|Jun 12, 2023
Drug-related catatonia in youths: real-world insights from the WHO Safety Database.

Diane Merino, Alexandre O Gérard, Thibaud Lavrut

Pageof 4

Frequent Collaborators

8 joint publications

Jean-Louis Montastruc

3 joint publications

Maryse Lapeyre-Mestre

3 joint publications

Geneviève Durrieu

2 joint publications

Justine Benevent